MedTrace Logo

Use of Low Dose of HCG During Ovulation Induction With CC in Women With CC Resistant PCOS

NCT02436226 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2023-10-31

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effect of administration of low dose of human chorionic gonadotropin (HCG) after use of clomiphene citrate (CC) for induction of ovulation in infertile women having CC resistant polycystic ovarian syndrome (PCOS).

Conditions

Interventions

DRUG

Clomiphene citrate and Human chorionic gonadotropin (HCG)

Women will receive clomiphene citrate (150 mg/day for 5 consecutive days from day 2 of cycle) and HCG (200 IU/day SC from day 7 of cycle)

DRUG

Clomiphene citrate

Women will receive clomiphene citrate (150 mg/day for 5 consecutive days from day 2 of cycle)

Sponsors & Collaborators

  • Mohamed Sayed Abdelhafez

    lead OTHER

Principal Investigators

  • Mahmoud Thabet, MD · Mansoura University

  • Khaled S Ismael, MD · Mansoura University

  • Ahmed Ragab, MD · Mansoura University

  • Maged R Elshamy, MD · Mansoura University

  • Mohamed A Elnegery, MD · Mansoura University

  • Hamed Youssef, MD · Mansoura University

  • Mahmoud M Abdel-razik, MD · Mansoura University

  • Mohamed S Abdelhafez, MD · Mansoura University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2023-01-31
Completion
2023-01-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02436226 on ClinicalTrials.gov